GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical

CHALFONT ST GILES, England:   GE HealthCare to acquire 50% stake from Sumitomo Chemical to assume full ownership of NMP,

READ MORE

ITM Obtains Exclusive Worldwide License from Debiopharm for CA IX-Targeted Peptide-based Radiopharmaceutical Programs Targeting Solid Tumors

Garching, Munich, Germany & Lausanne, Switzerland:   ITM gains exclusive global development and commercialization rights to Debiopharm’s first-in-class, peptide-based theranostic

READ MORE